Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Nuclear HER3 expression improves the prognostic stratification of patients with HER1 positive advanced laryngeal squamous cell carcinoma

Fig. 1

A Frequency of HER family phenotypes in LSCC of bioradiotherapy with cetuximab and in upfront surgery with or without postoperative radio/chemo-radiotherapy treated patients. Inside the bars: percentage of cases of each phenotype relative to total patient number in the group. B Frequency of HER family phenotypes in LSCC of both patient groups according to the grade of tumor differentiation

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us